News Article | November 16, 2016
Under the patronage of the Ministry of Health and Prevention - United Arab Emirates, The Emirates Gastroenterology & Hepatology Society (EGHS) has joint forces for the first time in the history of the World Gastroenterology Organisation (WGO), to jointly co-organise "Gastro 2016." 1,500 delegates from 80 countries will convene in Abu Dhabi National Exhibition Centre for 3 days from 17th to 19th November 2016 at the largest International Conference on Gastroenterology and Hepatology to ever take place in the region. Commenting on Gastro 2016, Dr. Yousif Al Serkal - Assistant Undersecretary for Hospitals Sector, UAE Ministry of Health and Prevention said: "I would like to use the opportunity of such eminent gathering of luminary experts and world leading minds in the fields of Gastroenterology & Hepatology, to re-emphasis the importance of combined efforts; by health authorities, organizations, research and education institutes; on an international scale, to combat the ever growing healthcare challenges facing our world today." Dr. Maryam Al Khatry - President of EGHS said: "I would like to extend our deepest appreciation to HE Abdel Rahman Al Owais, Minister of Health and Prevention for his continued support and to thank our WGO / EGHS colleagues and strategic partners for their efforts and support in bringing timely scientific knowledge and medical education to the region." "Gastro 2016 includes an outstanding lineup of key note lectures by 53 imminent world experts from 20 countries and a rich educational program with 327 oral and poster presentations showcasing research findings from 60 countries. We are also organizing live transmission sessions of endoscopy cases from Rashid Hospital, as well as the highly in demand "Hands-on Training" program with the capacity to cater for training over 600 physicians throughout the three days," she added. Prof. David Bjorkman's - WGO President said, "Gastro 2016 is already a remarkable success. We are keenly aware of the time and effort that has gone into this ambitious endeavor. The Scientific Program is superb offering content that addresses regional health issues as well as providing insights from a global perspective, all delivered by a world class faculty with representatives from the Middle East and around the world." "Following the international conference here in Abu Dhabi, the EGHS and WGO will also jointly convene a "Train the Trainers" workshop in Ras Al-Khaimah, bringing together educators from around the world, all with a desire to enhance their teaching skills and network with one another," he added. Gastro 2016 is supported by the Abu Dhabi Convention Bureau, the UAE Ministry of Health and Prevention as well as all the leading health care entities in the UAE. The Emirates Gastroenterology & Hepatology Society (EGHS) envisions itself as an organization of Gastroenterologists imbued with a high level of ethical values and committed to the beneficial exchange of knowledge among the fraternity of gastrointestinal practitioners. It also aims to dedicate itself to the development of systems by means of which research into understanding, prevention and cure of digestive diseases may be facilitated. The World Gastroenterology Organization is a global organization committed to bringing education, training and advocacy to low resource and underserved regions of the world. WGO is able to achieve its mission and objectives through close partnership with and through the commitment and efforts of its 111 member societies worldwide and 4 regional affiliate associations in Africa-Middle East, Asia Pacific, the Americas and Europe, who overall represent more than 50,000 gastroenterologists and other healthcare providers in related fields. For further information, please contact: Ms. Lina Alaa El Din Conference Secretariat c/o Meeting Minds Experts Tel: +9714-4270492 Email: firstname.lastname@example.org Or visit http://www.gastro2016.com
AbdullGaffar B.,Rashid Hospital |
Raman L.,Dubai Hospital |
Khamas A.,Rashid Hospital |
AlBadri F.,Rashid Hospital
Obesity Surgery | Year: 2016
Background: Laparoscopic sleeve gastrectomy (LSG) is a relatively new bariatric surgical procedure to reduce weight in morbidly obese patients, with an overall low rate of complications and thus gaining a worldwide popularity. It provides an opportunity to study the pathology of the stomach in obese patients. Most studies, however, focused on clinical aspects, surgical techniques, and postoperative complications. Few authors studied the histopathologic findings. Whether routine histopathologic examination is warranted in patients with grossly unremarkable LSG specimens and nonsignificant clinical history was not previously studied. Methods: We conducted a prospective study over 8 years to compare the prevalence, the morphologic spectrum and importance of histopathologic findings, and the frequency of incidental neoplasms in LSG specimens with other studies. We also proposed a protocol for the gross handling and sectioning of LSG specimens. Results: We found 546 LSG specimens. Five patients developed iatrogenic postoperative complications, two of which pursued a medicolegal case. There was no association between the histopathologic findings and the complications. Less than 1 % of incidental benign lesions were found. No malignancies were identified. All of the patients without postoperative complications had uneventful outcome after 5 months to 6 years follow-up. Conclusions: Routine microscopic examination of all LSG specimens is not necessary. Selective microscopic examination guided by relevant clinical history and macroscopic examination is a better option. This protocol will save money, time, and workload without compromising patient’s safety and future management. However, a careful gross description is still necessary in certain cases for potential future medicolegal implications. © 2015, Springer Science+Business Media New York.
Aldabal L.,Rashid Hospital |
Bahammam A.S.,King Saud University
Lung | Year: 2010
Cheyne-Stokes respiration (CSR) is a form of central sleep-disordered breathing (SDB) in which there are cyclical fluctuations in breathing that lead to periods of central apneas/hypopnea, which alternate with periods of hyperpnea. The crescendo-decrescendo pattern of respiration in CSR is a compensation for the changing levels of blood oxygen and carbon dioxide. Severe congestive heart failure seems to be the most important risk factor for the development of CSR. A number of pathophysiologic changes, such as sleep disruption, arousals, hypoxemia-reoxygenation, hypercapnia/hypocapnia, and changes in intrathoracic pressure have harmful effects on the cardiovascular system, and the presence of CSR is associated with increased mortality and morbidity in subjects with variable degrees of heart failure. The management of CSR involves optimal control of underlying heart failure, oxygen therapy, and positive airway pressure support. In this review, we initially define and describe the epidemiology of central sleep apnea (CSA) and CSR, its pathogenesis, clinical presentation, diagnostic methods, and then discuss the recent developments in the management in patients with heart failure. © 2009 Springer Science+Business Media, LLC.
Aldabal L.,Rashid Hospital |
Bahammam A.S.,King Saud University
Open Respiratory Medicine Journal | Year: 2011
Over the last three to four decades, it has been observed that the average total hours of sleep have decreased to less than seven hours per person per night. Concomitantly, global figures relating to obesity and diabetes mellitus have increased in an alarming fashion in adults and children, and it has been hypothesized that neuro-hormonal changes accompanying this behavioral sleep deprivation may lead to insulin resistance and, subsequently, to diabetes mellitus. Sleep deprivation has been associated with multiple physiological changes, including increased cortisol and ghrelin levels, decreased leptin levels and impaired glucose metabolism. Experimental studies have also shown an increase in inflammatory and pro-inflammatory markers, which are indicators of body stress, under sleep deprivation. This review elaborates further on this hypothesis, exploring the molecular basis for the link between both entities and the underlying pathophysiology that results in insulin resistance and diabetes mellitus. We review the results of experimental and epidemiological studies, specifically examining the relationship between sleep duration and the immune and endocrine systems. © AlDabal and BaHammam.
Abdullgaffar B.,Rashid Hospital
International Journal of Surgical Pathology | Year: 2014
The practice of self-injection of anabolic steroids (AS) in bodybuilders is common. AS are not the only materials used by bodybuilders for muscle augmentation or image enhancement. Other materials, for example, plant oils, silicon, Vaseline, and paraffin are also injected either in a pure form or mixed with AS. Muscle bulking is the main aim. However, bodybuilders undergo illicit injections for cosmetic, therapeutic, and sexual purposes. Even though the practice of unsupervised injection is probably common in the sports community, site-specific complications are underreported in the medical literature and mostly limited to case reports. Complications can be clinically and pathologically challenging because some can be confused with nonneoplastic and, more important, with neoplastic lesions. Bodybuilders are reluctant to disclose information because of stigma and legal issues. This study attempts to correlate the clinical manifestations and histomorphological features of different injected materials used for different purposes by bodybuilders in our region. A series of 11 cases out of 9 male bodybuilders was studied. A variety of clinical presentations and histological tissue reactions was identified, with some overlapping features between some cases. We identified 5 basic tissue reaction patterns depending on the injected materials, site, and duration of injection. Certain histological features provide useful hints in the absence of prior knowledge of injection history. However, in other cases, a retrospective enquiry by clinicians is warranted to avoid pitfalls. The medical and sports community should be aware of these injection-site complications. Bodybuilders should be discouraged from this practice by implementing appropriate educational and legislative measures. © The Author(s) 2014.
Abdullgaffar B.,Rashid Hospital
International journal of surgical pathology | Year: 2012
Intramammary lymph nodes (IntraMLNs) are frequent mostly benign incidental findings. However, they are clinically important because they can be the primary sites of metastasis and sentinel lymph nodes. Literature data regarding the clinical significance of IntraMLNs metastasis, however, remains controversial. This study aimed to perform a systematic review and meta-analysis to better define the prognostic value of positive IntraMLNs in patients with breast cancer. A systematic review of the literature without date restrictions was conducted. Five electronic medical databases were searched, and a hand-search of the reference lists of the collected articles was also performed. Studies with sufficient and relevant pathologic and clinical survival data were included. Other studies with insufficient data or normal findings were excluded. This study found 18 studies eligible for systematic review, 3 of which were eligible for outcome meta-analysis. IntraMLNs metastases were strongly correlated with axillary lymph nodes involvement. Positive IntraMLNs are reliable predictors of axillary lymph node involvement and therefore a guide for further surgical management of the axillary nodes. Even though it could be concluded that IntraMLNs metastasis is an independent predictor of outcome, this meta-analysis was limited because of the scarcity of data and the inconsistencies and heterogeneity of the outcome studies.
Abdullgaffar B.,Rashid Hospital
Acta Cytologica | Year: 2012
Objectives: Evidence-based medicine (EBM) relies on systematic review (SR), meta-analysis (MA) and randomized controlled trials (RCTs). These EBM tools are more commonly used in clinical medicine than in laboratory medicine. The extent of their use in cytopathology is not clear. The purpose of this study was to investigate the frequency of SR, MA and RCTs in cytopathology compared to other laboratory and clinical medicine specialties. Study Design: A literature-based search for SRs, MAs and RCTs in cytopathology was performed. Several electronic databases were searched without date restrictions. Four journals in cytopathology, pathology and clinical medicine were also searched over 6 years. Results: Gynecology cytology utilized SRs, MAs and RCTs more frequently (83%) than nongynecology and fine needle aspiration cytology. Cytopathology, histopathology and laboratory medicine journals showed comparable rates of 0.5-1.1% in papers reporting SRs, MAs and RCTs. Specialty medical journals showed a higher rate of 5.6% and general medical journals showed a much higher rate of 30%. Conclusions: SR, MA and RCTs are less frequently utilized in pathology than in clinical medicine. Cytopathologists should be more aware of the benefits of SR and MA in resolving uncertainties and improving the clinical applicability of level III diagnostic studies. Copyright © 2012 S. Karger AG, Basel.
Agarwal S.K.,Rashid Hospital
Cardiovascular Revascularization Medicine | Year: 2014
Dual antiplatelet therapy including aspirin and a P2Y12 ADP receptor antagonist is given after percutaneous coronary intervention to avoid catastrophic complication of stent thrombosis. Dual antiplatelet therapy is associated with increased bleeding risk and may not be tolerated by many patients. This article presents the patients, which had to be given single antiplatelet therapy after percutaneous coronary intervention and discusses the possible factors responsible for the success of single antiplatelet therapy strategy in these patients, in the current era of newer antiplatelet agents and coronary stents. © 2014 Elsevier Inc.
Agarwal S.K.,Rashid Hospital
Catheterization and Cardiovascular Interventions | Year: 2011
Thrombus remains the bane of interventional cardiology. The use of thrombus extraction devices and distal protection devices has been controversial. Pharmacological modulation using intracoronary (IC) thrombolytic therapy during percutaneous coronary intervention (PCI) is also not an established choice although intravenous thrombolytic therapy is widely accepted and applied treatment of choice for acute ST-elevation myocardial infarction (STEMI). This case report shows successful management of a patient of STEMI using a combination of IC thrombolytic therapy, thrombectomy device, and PCI. Copyright © 2011 Wiley-Liss, Inc.
El Hoseny S.M.,Rashid Hospital
Aesthetic Plastic Surgery | Year: 2010
Vitiligo is an acquired condition that presents as sharply demarcated white macules. It affects 1-2% of people of all races, regardless of gender or age. Although the disease does not have any systemic complications, it is of great concern, particularly in darker-skinned individuals. We treated 14 patients with vitiligo involving the upper and lower extremities. Surgical therapies were used in conjunction with medical therapy to achieve repigmentation after the disease was stabilized. © Springer Science+Business Media, LLC and International Society of Aesthetic Plastic Surgery 2009.